Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genmab A/S
Research & Development Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Research & Development
-kr8.8B
CAGR 3-Years
-75%
CAGR 5-Years
-36%
CAGR 10-Years
-32%
Zealand Pharma A/S
CSE:ZEAL
Research & Development
-kr789.5m
CAGR 3-Years
-23%
CAGR 5-Years
-10%
CAGR 10-Years
-18%
Ascendis Pharma A/S
NASDAQ:ASND
Research & Development
-€349.8m
CAGR 3-Years
-4%
CAGR 5-Years
-17%
CAGR 10-Years
-37%
B
Bavarian Nordic A/S
CSE:BAVA
Research & Development
-kr1.3B
CAGR 3-Years
-58%
CAGR 5-Years
-27%
CAGR 10-Years
-12%
F
Fluoguide AS
STO:FLUO
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Research & Development
-kr24m
CAGR 3-Years
2%
CAGR 5-Years
-8%
CAGR 10-Years
N/A

See Also

What is Genmab A/S's Research & Development?
Research & Development
-8.8B DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Research & Development amounts to -8.8B DKK.

What is Genmab A/S's Research & Development growth rate?
Research & Development CAGR 10Y
-32%

Over the last year, the Research & Development growth was -31%. The average annual Research & Development growth rates for Genmab A/S have been -75% over the past three years , -36% over the past five years , and -32% over the past ten years .

Back to Top